Skip to main content

Advertisement

Log in

Energy Homeostasis and Obesity: The Therapeutic Role of Anorexigenic and Orexigenic Peptide

  • Published:
International Journal of Peptide Research and Therapeutics Aims and scope Submit manuscript

Abstract

The brain detects changes in energy depots and actuates metabolic and behavioral responses planned to hold energy balance. Hunger, appetite, and satiety are often regarded as functions of the brain. In short, the hypothalamus opponent sets of the neuronal network: stimulatory and inhibitory—appetite neuronal network. This circuit is acted upon by hormone and sensory nervous signals that provide feedback and consolidative processing of nutritional status, energy intake and expenditure. The stimulatory appetite network released orexigenic neurotransmitter which encourages appetite, while anorexigenic neurotransmitter released by inhibitory appetite network decrease appetite. Knowledge about the physiology of appetite has immensely expanded in late years providing potential targets for anti-obesity drug design. This review furnishes a study of the peptides that have been concerned with appetite physiology and energy homeostasis and also includes their therapeutic application (agonist and antagonist).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

WHO:

World Health Organization

BMI:

Mass index

CCK:

Cholecystokinin

GLP-1:

Glucagon-like peptide-1

OXM:

Oxyntomodulin

PYY:

Peptide YY

NTS:

Nucleus tracts solitarius

GPCR-G:

Protein-coupled receptor

ARC:

Arcuate nucleus

VMN:

Ventromedial nuclei

IGF-2:

Insulin-like growth factor-2

POMC:

Preopiomelanocortin

AgRP:

Agouti-related protein

NPY:

Neuropeptide YY

CART:

Cocaine- and amphetamine-regulated transcript

PVN:

Paraventricular nucleus

DMH:

Dorsomedial hypothalamus

LHA:

Lateral hypothalamic area

CRH:

Corticotrophin releasing factor

LIF:

Leukaemia inhibitory factor

MSH:

Melanocyte stimulating hormone

References

  • Achari AE, Jain SK (2017) Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci 18(6):1321

    Article  CAS  PubMed Central  Google Scholar 

  • Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K, van den Pol AN (2005) Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci 25(32):7406–7419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Antin J, Gibbs J, Holt J, Young RC, Smith GP (1975) Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psychol 89(7):784–790

    Article  CAS  PubMed  Google Scholar 

  • Arora AS (2006) Role of neuropeptides in appetite regulation and obesity: a review. Neuropeptides 40(6):375–401

    Article  CAS  PubMed  Google Scholar 

  • Attané C, Daviaud D, Dray C, Dusaulcy R, Masseboeuf M, Prévot D, Carpéné C, Castan-Laurell I, Valet P (2011) Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo. J Mol Endocrinol 46(1):21–28

    Article  CAS  PubMed  Google Scholar 

  • Bäckberg M, Collin M, Ovesjö ML, Meister B (2003) Chemical coding of GABA(B) receptor-immunoreactive neurones in hypothalamic regions regulating body weight. J Neuroendocrinol 15(1):1–14

    Article  PubMed  Google Scholar 

  • Baggio LL, Huang Q, Brown TJ, Drucker DJ (2004) Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127(2):546–558

    Article  CAS  PubMed  Google Scholar 

  • Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB (1995) Permeability of the blood-brain barrier to amylin. Life Sci 57:1993–2001

    Article  CAS  PubMed  Google Scholar 

  • Bataille D, Tatemoto K, Gespach C, Jörnvall H, Rosselin G, Mutt V (1982) Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett 146(1):79–86

    Article  CAS  PubMed  Google Scholar 

  • Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2000) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418(6898):650–654

    Article  CAS  Google Scholar 

  • Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418(6898):650–654

    Article  CAS  PubMed  Google Scholar 

  • Beinfeld MC, Meyer DK, Eskay RL, Jensen RT, Brownstein MJ (1981) The distribution of cholecystokinin-immunoreactivity in the central nervous system of the rat, as determined by radioimmunoassay. Brain Res 212(1):51–57

    Article  CAS  PubMed  Google Scholar 

  • Bewick GA, Kent A, Campbell D, Patterson M, Ghatei MA, Bloom SR, Gardiner JV (2009) Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivity. Diabetes 58(4):840–846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blundell J (1991) Pharmacological approaches to appetite suppression. Trends Pharmacol Sci 12(4):147–157

    Article  CAS  PubMed  Google Scholar 

  • Brady LS, Smith MA, Gold PW, Herkenham M (1990) Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinol 52(5):441–447

    Article  CAS  Google Scholar 

  • Briggs DI, Andrews ZB (2011) Metabolic status regulates ghrelin function on energy homeostasis. Neuroendocrinology 93(1):48–57

    Article  CAS  PubMed  Google Scholar 

  • Briski KP, Sylvester PW (2001) Hypothalamic orexin-A-immunopositive neurons express Fos in response to central glucopenia. Neuroreport 12:531–534

    Article  CAS  PubMed  Google Scholar 

  • Broberger C, Landry M, Wong H, Walsh JN, Hokfelt T (1997) Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuro Endocrinol 166:393–408

    Google Scholar 

  • Burcelin R, Gourdy P (2017) Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity. Obes Rev 18(1):86–98

    Article  CAS  PubMed  Google Scholar 

  • Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141(9):3518–3521

    Article  CAS  PubMed  Google Scholar 

  • Castro MG, Morrison E (1997) Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol 11(1):35–57

    Article  CAS  PubMed  Google Scholar 

  • Chanoine JP, Wong AC (2004) Ghrelin gene expression is markedly higher in fetal pancreas compared with fetal stomach effect of maternal fasting. Endocrinology 145(8):3813–3820

    Article  CAS  PubMed  Google Scholar 

  • Chaudhri OB, Salem V, Murphy KG, Bloom SR (2008) Gastrointestinal satiety signals. Annu Rev Physiol 70:239–255

    Article  CAS  PubMed  Google Scholar 

  • Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, Cone RD (1997) Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine function by melanocortin peptides. Cell 91(6):789–798

    Article  CAS  PubMed  Google Scholar 

  • Chey WY, Sivasomboon B, Hendricks J (1973) Actions and interactions of gut hormones and histamine on gastric secretion of acid in the rat. Am J Physiol 224(4):852–856

    Article  CAS  PubMed  Google Scholar 

  • Cooper GJ (1994) Amylin compared with calcitonin gene-related peptide: structure, biology and relevance to metabolic disease. Endocr Rev 15(2):163–201

    Article  CAS  PubMed  Google Scholar 

  • Dafny N, Jacob RH, Jacobson ED (1975) Gastrointestinal hormones and neural interaction within the central nervous system. Experientia 31:658–660

    Article  CAS  PubMed  Google Scholar 

  • Dardevet D, Moore MC, Neal D, DiCostanzo CA, Snead W, Cherrington AD (2004) Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Am J Physiol Endocrinol Metab 287(1):E75–E81

    Article  CAS  PubMed  Google Scholar 

  • Date Y, Mondal MS, Matsukura S, Nakazato M (2000) Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett 288(2):87–90

    Article  CAS  PubMed  Google Scholar 

  • Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S (2002) Ghrelin is present in pancreatic alpha cells of humans and rats and stimulates insulin secretion. Diabetes 51(1):124–129

    Article  CAS  PubMed  Google Scholar 

  • De Mota N, Lenkei Z, Llorens-Cortès C (2000) Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 72(6):400–407

    Article  PubMed  Google Scholar 

  • De Falco M, De Luca L, Onori N, Cavallotti I, Artigiano F, Esposito V, De Luca B, Laforgia V, Groeger AM, De Luca A (2002) Apelin expression in normal human tissues. In Vivo 16(5):333–336

    PubMed  Google Scholar 

  • Dominguez G (2006) The CART gene: structure and regulation. Peptides 27(8):1913–1918

    Article  CAS  PubMed  Google Scholar 

  • Donnelly D (2012) The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol 166(1):27–41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434(7032):514–520

    Article  CAS  PubMed  Google Scholar 

  • Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK (1998) Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21(6):1375–1385

    Article  CAS  PubMed  Google Scholar 

  • Emily P (2010) Leptin: the satiety hormone and its influence on obesity. Eukaryon 6:80–83

    Google Scholar 

  • Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381(6581):415–421

    Article  CAS  PubMed  Google Scholar 

  • Ferrini F, Salio C, Lossi L, Merighi A (2009) Ghrelin in central neurons. Curr Neuropharmacol 7(1):37–49

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586

    Article  CAS  PubMed  Google Scholar 

  • Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704):763–770

    Article  CAS  PubMed  Google Scholar 

  • Geary N (2004) Endocrine controls of eating: CCK, leptin, and ghrelin. Physiol Behav 81(5):719–733

    Article  CAS  PubMed  Google Scholar 

  • Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87(6):2988

    Article  CAS  PubMed  Google Scholar 

  • Gu XC, Zhang XB, Hu B, Zi Y, Li M (2016) Neuropeptide Y accelerates post-fracture bone healing by promoting osteogenesis of mesenchymal stem cells. Neuropeptides 60:61–66

    Article  CAS  PubMed  Google Scholar 

  • Guillod-Maximin E, Roy AF, Vacher CM, Aubourg A, Bailleux V, Lorsignol A, Pénicaud L, Parquet M, Taouis M (2009) Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons. J Endocrinol 200(1):93–105

    Article  CAS  PubMed  Google Scholar 

  • Guzik TJ, Mangalat D, Korbut R (2006) Adipocytokines—novel link between inflammation and vascular function. J Physiol Pharmacol 57(4):505–528

    CAS  PubMed  Google Scholar 

  • Harrold JA, Dovey TM, Blundell JE, Halford JC (2012) CNS regulation of appetite. Neuropharmacology 63:3–17

    Article  CAS  PubMed  Google Scholar 

  • Hart BL (1998) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12(2):123–137

    Article  Google Scholar 

  • Heinrichs SC, Lapsansky J, Behan DP, Chan RKW, Sawchenko PE, Lorang M, Ling N, Vale WW, De Souza EB (1996) Corticotropin-releasing factor-binding protein-ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci USA 93:15475–15480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R, Göke B (1995) Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56(2):117–126

    Article  CAS  PubMed  Google Scholar 

  • Hjuler ST, Gydesen S, Andreassen KV, Pedersen SL, Hellgren LI, Karsdal MA, Henriksen K (2016) The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity. Obesity 24(8):1712–1722

    Article  CAS  PubMed  Google Scholar 

  • Holmqvist T, Johansson L, Ostman M, Ammon S, Akerman KE, Kukkonen JP (2005) OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J Biol Chem 280(8):6570–6579

    Article  CAS  PubMed  Google Scholar 

  • Holzer P, Reichmann F, Farzi A (2012) Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides 46(6):261–274

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunter RG, Philpot K, Vicentic A, Dominguez G, Hubert GW, Kuhar MJ (2004) CART in feeding and obesity. Trends Endocrinol Metab 15(9):454–459

    Article  CAS  PubMed  Google Scholar 

  • Iepsen EW, Lundgren J, Dirksen C, Jensen JE, Pedersen O, Hansen T, Madsbad S, Holst JJ, Torekov SS (2015) Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. Int J Obes 39(5):834–841

    Article  CAS  Google Scholar 

  • Irwin N, Frizelle P, Montgomery IA, Moffett RC, O’Harte FPM, Flatt PR (2012) Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes. Diabetologia 55(10):2747–2758

    Article  CAS  PubMed  Google Scholar 

  • Isaacs D, Prasad-Reddy L, Srivastava SB (2016) Role of glucagon-like peptide 1 receptor agonists in management of obesity. Am J Health Syst Pharm 73(19):1493–1507

    Article  PubMed  Google Scholar 

  • Jacqueline SE (2011) Melanocortin MC4 receptor expression sites and local function. Eur J Pharmacol 660:234–240

    Article  CAS  Google Scholar 

  • Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, Sharma S, Neilson I, Webb DJ, Megson IL, Flapan AD, Newby DE (2008) Vascular effects of apelin in vivo in man. J Am Coll Cardiol 52(11):908–913

    Article  CAS  PubMed  Google Scholar 

  • Jégou S, Boutelet I, Vaudry H (2000) Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J Neuroendocrinol 12(6):501–505

    Article  PubMed  Google Scholar 

  • Jia R, Li M, Chang B, Chen L, Ma J (2015) Expression of neuropeptide Y and its relationship with molecular and morphological changes in human pituitary adenomas. Cancer Biother Radiopharm 30(10):411–419

    Article  CAS  PubMed  Google Scholar 

  • Kadowaki T, Yamauchi T, Kubota N (2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582(1):74–80

    Article  CAS  PubMed  Google Scholar 

  • Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Van der Ploeg LH, Saga Y, Nishimura S, Ihara M (2000) Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141(3):1011–1016

    Article  CAS  PubMed  Google Scholar 

  • Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C (2012) Brain orexin promotes obesity resistance. Ann N Y Acad Sci 1264:72–86

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M, Nakamura M (1998) Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA 95(26):15659–15664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee CJ, Yun JH, Lim SK, Lee W (2010) Solution structures and molecular interactions of selective melanocortin receptor antagonists. Mol Cells 30(6):551–556

    Article  CAS  PubMed  Google Scholar 

  • Li F, Fisher KJ, Harmer P (2005) Prevalence of overweight and obesity in older U.S. adults: estimates from the 2003 Behavioral Risk Factor Surveillance System survey. J Am Geriatr Soc 53(4):737–739

    Article  PubMed  Google Scholar 

  • Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppressant. Nature 394(6696):897–901

    Article  CAS  PubMed  Google Scholar 

  • Lovenberg TM, Liaw CW, Grigoriadis DF, Clevenger W, Chalmers DT, Desouza EB, Olsterdorf T (1995) Cloning and characterization of functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836–840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lu Q, Feng J, Jiang Y (2013) The role of apelin in the retina of diabetic rats. PLoS ONE 8(7):e69703

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Malabu UH, McCarthy HD, McKibbin PE, Williams G (1992) Peripheral insulin administration attenuates the increase in neuropeptide Y concentrations in the hypothalamic arcuate nucleus of fasted rats. Peptides 13:1097–1102

    Article  CAS  PubMed  Google Scholar 

  • Marathe CS, Rayner CK, Jones KL, Horowitz M (2013) Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides 44:75–86

    Article  CAS  PubMed  Google Scholar 

  • Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4(6):718–721

    Article  CAS  PubMed  Google Scholar 

  • Meier JJ, Nauck MA (2005) Glucagon-like peptide 1 (GLP-1) in biology and pathology. Diabetes Metab Res Rev 21(2):91–117

    Article  CAS  PubMed  Google Scholar 

  • Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev 50(1):143–150

    CAS  PubMed  Google Scholar 

  • Mieda M, Yanagisawa M (2002) Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors. Curr Opin Neurobiol 12(3):339–345

    Article  CAS  PubMed  Google Scholar 

  • Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localisation of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8(10):1298–1308

    CAS  PubMed  Google Scholar 

  • Müller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, Batterham RL, Benoit SC, Bowers CY, Broglio F, Casanueva FF (2015) Ghrelin. Mol Metab 4(6):437–460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nature 444(7121):854–859

    Article  CAS  PubMed  Google Scholar 

  • Myers MG Jr, White MF (1996) Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol 36:615–658

    Article  CAS  PubMed  Google Scholar 

  • Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409(6817):194–198

    Article  CAS  PubMed  Google Scholar 

  • Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM (1999) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 23(3):304–311

    Article  PubMed  Google Scholar 

  • Neary MT, Batterham RL (2009) Peptide YY: food for thought. Physiol Behav 97(5):616–619

    Article  CAS  PubMed  Google Scholar 

  • Nishi Y, Hiejima H, Hosoda H, Kaiya H, Mori K, Fukue Y, Yanase T, Nawata H, Kangawa K, Kojima M (2005) Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146(5):2255–2264

    Article  CAS  PubMed  Google Scholar 

  • Niswender KD, Schwartz MW (2003) Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 24(1):1–10

    Article  CAS  PubMed  Google Scholar 

  • Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers MG Jr, Seeley RJ, Schwartz MW (2003) Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52(2):227–231

    Article  CAS  PubMed  Google Scholar 

  • O’Shea M, Hansen MJ, Tatemoto K, Morris MJ (2003) Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 6(3):163–167

    Article  CAS  PubMed  Google Scholar 

  • Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278(5335):135–138

    Article  CAS  PubMed  Google Scholar 

  • Perry B, Wang Y (2012) Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes 2(1):e26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Plum L, Belgardt BF, Bruning JC (2006) Central insulin action in energy and glucose homeostasis. J Clin Invest 116(7):1761–1766

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pocai A (2013) Action and therapeutic potential of oxyntomodulin. Mol Metab 3(3):241–251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Porte D Jr, Baskin DG, Schwartz MW (2002) Leptin and insulin action in the central nervous system. Nutr Rev 60(10 Pt 2):S20–S29

    Article  PubMed  Google Scholar 

  • Porte D Jr, Baskin DG, Schwartz MW (2005) Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54(5):1264–1276

    Article  CAS  PubMed  Google Scholar 

  • Prinz P, Stengel A (2017) Control of food intake by gastrointestinal peptides: mechanisms of action and possible modulation in the treatment of obesity. J Neurogastroenterol Motil 23(2):180–196

    Article  PubMed  PubMed Central  Google Scholar 

  • Richard D, Rivest R, NaõÈmi N, Timofeeva E, Rivest S (1996) Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 137:4786–4795

    Article  CAS  PubMed  Google Scholar 

  • Richard D, Huang Q, Timofeeva E (2000) The corticotropin-releasing hormone system in the regulation of energy balance in obesity. Int J Obes 24(S2):S36

    Article  CAS  Google Scholar 

  • Rindi G, Terenghi G, Westermark G, Westermark P, Moscoso G, Polak JM (1991) Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice. Am J Pathol 138(6):1321–1334

    CAS  PubMed  PubMed Central  Google Scholar 

  • Rogge G, Jones D, Hubert GW, Lin Y, Kuhar M (2008) CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 9(10):747–758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roujeau C, Jockers R, Dam J (2014) New pharmacological perspectives for the leptin receptor in the treatment of obesity. Front Endocrinol 5:167

    Article  Google Scholar 

  • Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell 92(4):573–585

    Article  CAS  PubMed  Google Scholar 

  • Salomé N, Haage D, Perrissoud D, Moulin A, Demange L, Egecioglu E, Fehrentz JA, Martinez J, Dickson SL (2009) Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats. Eur J Pharmacol 612(1–3):167–173

    Article  CAS  PubMed  Google Scholar 

  • Sam AH, Troke RC, Tan TM, Bewick GA (2012) The role of the gut/brain axis in modulating food intake. Neuropharmacology 63(1):46–56

    Article  CAS  PubMed  Google Scholar 

  • Sawchenko PE, Swanson LW (1985) Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44:221–227

    CAS  PubMed  Google Scholar 

  • Schepp W, Dehne K, Riedel T, Schmidtler J, Schaffer K, Classen M (1996) Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7–36) NH2, Digestion 57(6):398–405

    Article  CAS  PubMed  Google Scholar 

  • Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404(6778):661–671

    Article  CAS  PubMed  Google Scholar 

  • Shimabukuro M (2017) Leptin resistance and lipolysis of white adipose tissue: an implication to ectopic fat disposition and its consequences. J Atheroscler Thromb 24(11):1088–1089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL (1997) Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11(5):593–602

    Article  CAS  PubMed  Google Scholar 

  • Sunter D, Hewson AK, Dickson SL (2003) Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 353(1):1–4

    Article  CAS  PubMed  Google Scholar 

  • Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165–186

    Article  CAS  PubMed  Google Scholar 

  • Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M, Bloom S (2002) The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 291(5):1208–1212

    Article  CAS  PubMed  Google Scholar 

  • Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000) Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24(7):861–868

    Article  CAS  PubMed  Google Scholar 

  • Tao YX (2002) The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev 31(4):506–543

    Article  CAS  Google Scholar 

  • Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sönksen PH (1986) The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia 29(3):131–141

    Article  CAS  PubMed  Google Scholar 

  • Vadim K, Anna-Maria AHP, Nick K, Jason P, Heather Myler LS (2009) Modified leptin polypeptides and their uses. European Patent Office: WO2009100255 A2

  • Wahlestedt C, Regunathan S, Reis DJ (1992) Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci 50(4):PL7–P12

    Article  CAS  PubMed  Google Scholar 

  • Wank SA (1995) Cholecystokinin receptors. Am J Physiol 269(5 Pt 1):G628–G646

    CAS  PubMed  Google Scholar 

  • Whitnall MH (1993) Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40:573–629

    Article  CAS  PubMed  Google Scholar 

  • WHO Consultation (2017) Epidemic report of a WHO consultation (WHO technical report series 894). http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/. Accessed 23 Oct 2017

  • Wilding JP (2002) Neuropeptides and appetite control. Diabet Med 19(8):619–627

    Article  CAS  PubMed  Google Scholar 

  • Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391(6670):900–904

    Article  CAS  PubMed  Google Scholar 

  • Wook K, Josephine EM (2008) The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 60(4):470–512

    Article  CAS  Google Scholar 

  • Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86(12):5992

    Article  CAS  PubMed  Google Scholar 

  • Xu L, Qu Z, Guo F, Pang M, Gao S, Zhu H, Gu F, Sun X (2013) Effects of ghrelin on gastric distention sensitive neurons in the arcuate nucleus of hypothalamus and gastric motility in diabetic rats. Peptides 48:137–146

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941):762–769

    Article  CAS  PubMed  Google Scholar 

  • Yang R, Barouch LA (2007) Leptin signaling and obesity: cardiovascular consequences. Circ Res 101(6):545–559

    Article  CAS  PubMed  Google Scholar 

  • Yeo GS, Farooqi IS, Challis BG, Jackson RS, O’Rahilly S (2000) The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. QJM 93(1):7–14

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432

    Article  CAS  PubMed  Google Scholar 

  • Zhou J, Cai X, Huang X, Dai Y, Sun L, Zhang B, Yang B, Lin H, Huang W, Qian H (2017) A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects. Eur J Med Chem 138:1158–1169

    Article  CAS  PubMed  Google Scholar 

  • Zimanyi IA, Fathi Z, Poindexter GS (1998) Central control of feeding behavior by neuropeptide Y. Curr Pharm Des 4(4):349–366

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chirag A. Patel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, C.A., Acharya, S.R. Energy Homeostasis and Obesity: The Therapeutic Role of Anorexigenic and Orexigenic Peptide. Int J Pept Res Ther 25, 919–932 (2019). https://doi.org/10.1007/s10989-018-9740-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10989-018-9740-7

Keywords

Navigation